Tulmimetostat DL1 QD: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

8

US states with sites

14

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

Condition	Trials
Progressive Metastatic Castrate Resistant Prostate Cancer	1
Prostate cancer	1

Recruiting trials involving Tulmimetostat DL1 QD

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
NCT07206056 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 35 locations

Common questions

How many recruiting trials involve Tulmimetostat DL1 QD?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.